Fellowship House Inc is a licensed substance use treatment provider in Birmingham, AL, listed in the SAMHSA treatment directory. Long term residential treatment is available for people who need more than a short stay. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientResidential/24-hour residentialOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentLong-term residential
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsCash or self-paymentSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentState department of health
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
530 Beacon Parkway West, Suite 300, Birmingham, AL 35209
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsNo payment accepted